Development of nicardipine prolonged-release implants for preventing vasospasm

Acta Neurochirurgica, Supplement

Volumn 77, Issue , 2001, Pages 217-220

  Kasuya, H ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cerebral vasospasm; Copoly(lactic glycolic acid); Drug delivery system; Nicardipine

Indexed keywords

NICARDIPINE; VASODILATOR AGENT;

ANIMAL; ARTICLE; BLOOD; BRAIN VASOSPASM; CEREBROSPINAL FLUID; DOG; DOSE RESPONSE; DRUG IMPLANT; IN VITRO STUDY; SUBARACHNOID HEMORRHAGE;

ANIMALS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; NICARDIPINE; SUBARACHNOID HEMORRHAGE; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 0035228726     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6232-3_46     Document Type: Article

References (2)

1. Athanasiou KA, Niederauer GG, Agrawal CM (1996) Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 17:93-102
2. Kawashima A, Kasuya H, Shiokawa K, Miyajima M, Izawa M, Takakura K (1998) Efficacy of nicardipine prolonged-release pellet on cerebral vasospasm in dogs. No Shinkei Geka (Jpn) 26: 37-43